Kate is a Medical Oncologist at Chris O’Brien Lifehouse / Royal Prince Alfred Hospital and a post-doctoral research fellow at the Garvan Institute for Medical Research. Her current advanced prostate cancer research is primarily focused on implementing effective biomarkers into clinical practice.